“EARLY DETERMINATION RISKS OF ATHEROSCLEROSIS IN THE PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE”, ijms, vol. 5, no. 12, pp. 1019–1023, Dec. 2025, doi: 10.55640/.